Literature DB >> 17609769

Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin.

Jaromír Mikes1, Ján Kleban, Veronika Sacková, Viktor Horváth, Erika Jamborová, Alena Vaculová, Alois Kozubík, Jirina Hofmanová, Peter Fedorocko.   

Abstract

Photodynamic therapy (PDT) represents a new rapidly-developing anticancer approach based on administration of a non- or weakly-toxic photosensitizer and its activation with light of appropriate wavelength. Hypericin, one of the promising photosensitizers, is known to induce apoptosis with high efficiency in various cell line models. However, here we report the prevalence of necrosis accompanied by suppression of caspase-3 activation in colon adenocarcinoma HT-29 cells exposed to an extensive range of PDT doses evoked by variations in two variables -- hypericin concentration and light dose. Necrosis was the principal mode of cell death despite different PDT doses and the absence of anti-apoptotic Bcl-2 expression, even if the same condition induced caspase-3 activity at similar toxicity in HeLa cells. Introduction of Bcl-2 into HT-29 cells invoked caspase-3 activation, changed the Bcl-X(L) expression pattern, increased the apoptosis ratio with no effect on overall toxicity, and supported arrest in the G(2)/M-phase of cell cycle. Since it is known that Bcl-2 suppression in HT-29 is reversible and linked to the over-expression of mutated p53 and also considering our data, we suggest that the mutation in p53 and events linked to this feature may play a role in cell death signalling in HT-29 colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609769     DOI: 10.1039/b700350a

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  7 in total

1.  Ultrasound Triggers Hypericin Activation Leading to Multifaceted Anticancer Activity.

Authors:  Federica Foglietta; Roberto Canaparo; Simone Cossari; Patrizia Panzanelli; Franco Dosio; Loredana Serpe
Journal:  Pharmaceutics       Date:  2022-05-21       Impact factor: 6.525

Review 2.  Hypericins as potential leads for new therapeutics.

Authors:  Anastasia Karioti; Anna Rita Bilia
Journal:  Int J Mol Sci       Date:  2010-02-04       Impact factor: 5.923

3.  Alterations in dysadherin expression and F-actin reorganization: a possible mechanism of hypericin-mediated photodynamic therapy in colon adenocarcinoma cells.

Authors:  Aysun Kılıç Süloğlu; Güldeniz Selmanoğlu; M Turan Akay
Journal:  Cytotechnology       Date:  2014-02-08       Impact factor: 2.058

4.  Photofrin binds to procaspase-3 and mediates photodynamic treatment-triggered methionine oxidation and inactivation of procaspase-3.

Authors:  Y-J Hsieh; K-Y Chien; S-Y Lin; S Sabu; R-M Hsu; L-M Chi; P-C Lyu; J-S Yu
Journal:  Cell Death Dis       Date:  2012-07-12       Impact factor: 8.469

Review 5.  Many stimuli pull the necrotic trigger, an overview.

Authors:  N Vanlangenakker; T Vanden Berghe; P Vandenabeele
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

6.  A NIR-I light-responsive superoxide radical generator with cancer cell membrane targeting ability for enhanced imaging-guided photodynamic therapy.

Authors:  Yingcui Bu; Tianren Xu; Xiaojiao Zhu; Jie Zhang; Lianke Wang; Zhipeng Yu; Jianhua Yu; Aidong Wang; Yupeng Tian; Hongping Zhou; Yi Xie
Journal:  Chem Sci       Date:  2020-09-05       Impact factor: 9.825

Review 7.  Hypericin in the Light and in the Dark: Two Sides of the Same Coin.

Authors:  Zuzana Jendželovská; Rastislav Jendželovský; Barbora Kuchárová; Peter Fedoročko
Journal:  Front Plant Sci       Date:  2016-05-06       Impact factor: 5.753

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.